Browse Companies by Terms

Copy and paste the "+" delimited list of TIDs into the "Arguments" field of the BTC Company Activity Group page.

The number in () represents all content associated with the term. Thus it may not match the number of organizations selected.

Arguments: 641

Export the list

Selected Terms: id:641 T-Cells (43)

41 Organization(s) Selected

You can select up to 55 terms.
If nothing is returned, you probably have to many items selected.

Achilles Therapeutics

Description: 

Achilles Therapeutics is a biopharmaceutical company developing personalized T cell ...

Adaptimmune

Description: 

Revolutionizing cancer therapy on a global basis by developing TCR ...

Adaptive Biotechnologies

Description: 

T Cell and B Cell receptor analysis with Clonoseq.

Adicet Bio

Business Area(s): 
Description: 

Working on off-the-shelf cellular therapies that may offer the anticancer ...

Artielle ImmunoTherapeutics

Business Area(s): 
Description: 

Recombinant T Cell Receptor Ligands

Atara Biotherapeutics

Description: 

Atara Bio’s programs include T-cell product candidates and molecularly-targeted product ...

Autolus

Description: 

Autolus is at the forefront of a revolution in cancer ...

AVM Biotechnology

Description: 

Stem Cell Technologies, Fully Human Biologics Manufacturing Cell Lines, Regenerative ...

Bellicum Pharmaceuticals

Description: 

Develops next-generation product candidates in some of the most important ...

Biotecnol

Business Area(s): 
Description: 

Antibody technology

Bluebird Bio

Description: 

The cancer immunotherapy research group is focused on the next ...

Cell Medica

Business Area(s): 
Description: 

Cell Medica develops therapeutics based on cellular immunotherapy with the ...

Cellectis

Description: 

Designing next generation immunotherapies based on gene-edited CAR T-cells

Chimera Bioengineering

Business Area(s): 
Description: 

Chimera Bioengineering solves the challenges of CAR-Ts with RNA-based gene ...

CytomX Therapeutics

Description: 

Develops cancer immunotherapies, drug conjugates (PDCs), T-cell engaging Probody bispecifics ...

Harpoon Therapeutics

Business Area(s): 
Description: 

Harpoon Therapeutics is a clinical-stage immuno-oncology company developing a novel ...

Immunocore

Business Area(s): 
Description: 

Develops ImmTAC® (Immune mobilising monoclonal TCRs against cancer). These molecules ...

iTeos Therapeutics

Business Area(s): 
Description: 

iTeos Therapeutics is targeting the tumor microenvironment to enhance the ...

Juno Therapeutics

Description: 

The company leverages two technologies—CARs and TCRs—to activate a patient’s ...

Lion Biotechnologies

Description: 

Develops tumor-infiltrating T cells designed to overcome the immunosuppressive effects ...

Medigene

Business Area(s): 
Description: 

Medigene concentrates on the development of personalized T cell-based immunotherapies. ...

MIODx

Description: 

The MIODx ClonoMap platform can sequence and analyze TCR and ...

Mustang Bio

Description: 

Mustang Bio, Inc., a subsidiary of Fortress Biotech, Inc., is ...

Nanjing Legend Pharmaceutical & Chemical

Business Area(s): 
Description: 

Nanjing Legend Pharmaceutical & Chemical Co., Ltd is a research-based ...

NantKwest

Description: 

Develops immunotherapeutics that activate natural killer cells.

NKT Therapeutics

Business Area(s): 
Description: 
Natural Killer T-Cell Therapeutics

Okairos

Business Area(s): 
Description: 
T-Cell Based Vaccines

Osivax

Business Area(s): 
Description: 

Clinical-stage biotech company developing vaccines and ​immunotherapies eliciting powerful CD8+ ...

Oxford Vacmedix

Business Area(s): 
Description: 

Develops peptides to stimulate cytotoxic T-Cells.

PACT Pharma

Description: 

Developing personalized adoptive cell therapies with neoantigen-targeted T Cells against ...

Poseida Therapeutics

Description: 

Poseida Therapeutics is a spin out of Transposagen Biopharmaceuticals that ...

Root Path

Business Area(s): 
Description: 

RootPath is a Cambridge-based biotechnology company developing a personalized T ...

Sorrento Therapeutics

Description: 

Developing novel immunotherapies against medically-relevant targets utilizing Sorrento’s unique portfolio ...

TapImmune

Description: 

An immuno-oncology company developing vaccine technologies for the treatment of ...

Tempero Pharmaceuticals

Business Area(s): 
Description: 
T Cell Balance Therapies

Tmunity

Business Area(s): 
Description: 

Tmunity is developing a diversified portfolio of novel treatments that ...

TScan Therapeutics

Business Area(s): 
Description: 

TScan is developong T cell therapies.

Vor BioPharma

Description: 

Vor BioPharma is working to develop engineered hematopoietic stem cells ...

Xenetic Biosciences

Description: 

Xenetic Biosciences is a biopharmaceutical company focused on the acquisition, ...

Xyphos

Business Area(s): 
Description: 

Xyphos’ convertibleCAR technology exploits a powerful immune surveillance pathway involving ...

Don't see an employer? Please fill out the form